英国Almac Group   www.almacgroup.com 
Almac Clinical Technologies公司是Almac Group的子公司，专门致力于互动技术及服务解决方案，以提高临床试验流程的质量和效率。我们的解决方案包括针对随机患者、跟踪和临床应用管理的互动电话及网络回应系统(IXRS(TM))、用于电子化病例报告表数据收集的iTrial EDC、电子化患者报告结果数据收集以及网络化药品清单。Almac公司的技术在1300多项临床试验中得到了应用，涉及80多个国家，讲50多种语言的150万患者。
关于Almac Group
Almac Group由五家紧密结合的子公司组成，提供从研发、基因翻译服务、API生产、配方研发、临床试验应用和技术（IVRS/EDC），到大规模生产的广泛服务。Almac公司向包括制药和生物技术领域的全球所有领先企业在内的600多家公司提供服务。公司拥有员工2000多名，总部位于北爱尔兰的Craigavon，并在宾夕法尼亚州、北卡罗莱纳州和加利福尼亚州开展美国业务。公司2008年7月投资1亿美元开始兴建新的北美总部，预计工程将于2010年竣工
Almac Group provides world-class, integrated solutions to the global pharmaceutical and biotechnology industries. Our services include process R&D, custom synthesis of API; micronization, 14C radio-labeling, formulation and analytical development; commercial-scale manufacture; packaging; storage; QP release; supply chain management; diagnostic/genomic services, preparation of clinical supplies and technology solutions (IVRS /Web/EDC). 
Almac has the most comprehensive range of integrated drug development services available to the pharmaceutical / biotech industry. The privately owned company employing 2,200 dedicated professionals, is headquartered in Craigavon, Northern Ireland and has extensive facilities in the UK and US. Over 600 companies worldwide, including all the market leaders, use our services, testament itself to the quality, innovation and efficiency of our business. Click here to view our corporate video.
Almac's world-class pharmaceutical solutions extend from research, through development, to the commercialisation of product: